US Patent
US9731082 — Drug container
Formulation · Assigned to Fresenius Kabi Deutschland GmbH · Expires 2032-04-23 · 6y remaining
Vulnerability score
48/100
Strong — defensible against typical IPR challenges
What this patent protects
This patent protects an assembly of an injection device with a heat-shrinkable film covering parts of the device and an adaptor to maintain the adaptor in place.
USPTO Abstract
The present invention relates to an assembly ( 101 ) comprising: an injection device ( 1 ) comprising a container ( 2 ) for a product, said container comprising a distal tip ( 3 ), an adaptor ( 5 ) comprising a ring ( 6 ) mounted onto said distal tip ( 3 ), characterized in that said assembly ( 101 ) further comprises a heat-shrinkable film ( 9 ) covering part ( 2 a ) of said container ( 2 ) and part ( 5 a ) of said adaptor ( 5 ), said film ( 9 ) maintaining said adaptor ( 5 ) blocked in rotation and in translation with respect to said container ( 2 ) when said film ( 9 ) is in its heat-shrunk condition. The invention further relates to a method for manufacturing such an assembly.
Drugs covered by this patent
- Dilaudid-Hp (Hydromorphone Hydrochloride) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.